← Leaderboards
Katherine A Janeway
Broad Institute, Inc.
$362,961
Attributed
$362,961
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.4M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,985,073 · 2
By mechanism
U2C$16,985,073 · 2
Top collaborators
- Suzanne George4 shared
- Jennifer W Mack4 shared
- Eliezer M Van Allen4 shared
- Nikhil Wagle2 shared
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Heidi L Rehm$158,514,803
- Erin Rooney Riggs$6,956,402
- Corrie Ann Painter$5,899,297
- Gad A Getz$28,676,822
- Mark J Daly$79,238,345
Others in their field
Other Emerging Leaders on “Data Science”
- Leonard Freedman · Leidos Biomedical Research, Inc.$821,386,641
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$266,822,647
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Lynn Briscoe · Leidos Biomedical Research, Inc.$238,999,069
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Leonard Freedmand · Leidos Biomedical Research, Inc.$153,205,657
Research focus
Data ScienceFailureData De-IdentificationData ReportingConsentDiagnostic ProcedureClinical ResearchDatabasesCommunitiesClinical TrialsComputational BiologyBloodBoneComputer AnalysisAdultClinical DatabaseBehavioral ResearchDana-Farber Cancer InstituteCaringBehavioral SciencesChildChildhoodClinical DataGenome
Grant awards (7)
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$3,418,624
U2C · FY2025 · CA · contact PI
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$2,950,685
U2C · FY2024 · CA · contact PI
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$1,849,405
U2C · FY2023 · CA · contact PI
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$2,027,859
U2C · FY2022 · CA · contact PI
Administrative Core$362,961
U2C · FY2022 · CA · contact PI
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$3,210,930
U2C · FY2021 · CA
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults$3,164,609
U2C · FY2020 · CA